Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
2p21-p16.3 | Lynch syndrome 1 | 120435 | AD | 3 | MSH2 | 609309 |
Location | Phenotype | Inheritance |
Phenotype mapping key |
Phenotype MIM number |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
2p21 | Lynch syndrome 8 | AD | 3 | 613244 | EPCAM | 185535 |
2p21-p16.3 | Lynch syndrome 1 | AD | 3 | 120435 | MSH2 | 609309 |
2p16.3 | Lynch syndrome 5 | AD | 3 | 614350 | MSH6 | 600678 |
3p24.1 | Colorectal cancer, hereditary nonpolyposis, type 6 | 3 | 614331 | TGFBR2 | 190182 | |
3p22.2 | Lynch syndrome 2 | 3 | 609310 | MLH1 | 120436 | |
7p22.1 | Lynch syndrome 4 | 3 | 614337 | PMS2 | 600259 | |
14q24.3 | Colorectal cancer, hereditary nonpolyposis, type 7 | 3 | 614385 | MLH3 | 604395 |
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
1p36.13 | {?Colorectal cancer, susceptibility to} | 114500 | AD, SMu | 3 | PLA2G2A | 172411 |
1p13.2 | Colorectal cancer, somatic | 114500 | 3 | NRAS | 164790 | |
2q13 | Colorectal cancer with chromosomal instability, somatic | 114500 | 3 | BUB1 | 602452 | |
3p22.1 | Colorectal cancer, somatic | 114500 | 3 | CTNNB1 | 116806 | |
3q26.32 | Colorectal cancer, somatic | 114500 | 3 | PIK3CA | 171834 | |
4p16.3 | Colorectal cancer, somatic | 114500 | 3 | FGFR3 | 134934 | |
4q31.3 | {Colorectal cancer, susceptibility to} | 114500 | AD, SMu | 3 | TLR2 | 603028 |
5q22.2 | Colorectal cancer, somatic | 114500 | 3 | APC | 611731 | |
5q22.2 | Colorectal cancer, somatic | 114500 | 3 | MCC | 159350 | |
7q11.23 | Colon cancer, somatic | 114500 | 3 | PTPN12 | 600079 | |
7q34 | Colorectal cancer, somatic | 114500 | 3 | BRAF | 164757 | |
8p22 | Colorectal cancer, somatic | 114500 | 3 | DLC1 | 604258 | |
8p22 | Colorectal cancer, somatic | 114500 | 3 | PDGFRL | 604584 | |
8q22.1 | Colon cancer, somatic | 114500 | 3 | RAD54B | 604289 | |
11p11.2 | Colon cancer, somatic | 114500 | 3 | PTPRJ | 600925 | |
11q13.3 | {Colorectal cancer, susceptibility to} | 114500 | AD, SMu | 3 | CCND1 | 168461 |
14q24.3 | Colorectal cancer, somatic | 114500 | 3 | MLH3 | 604395 | |
14q32.33 | Colorectal cancer, somatic | 114500 | 3 | AKT1 | 164730 | |
15q15.1 | Colorectal cancer, somatic | 114500 | 3 | BUB1B | 602860 | |
17p13.1 | {Colorectal cancer} | 114500 | AD, SMu | 3 | TP53 | 191170 |
17p11.2 | Colorectal cancer, somatic | 114500 | 3 | FLCN | 607273 | |
17q24.1 | Colorectal cancer, somatic | 114500 | 3 | AXIN2 | 604025 | |
18q21.2 | Colorectal cancer, somatic | 114500 | 3 | DCC | 120470 | |
19q13.33 | Colorectal cancer, somatic | 114500 | 3 | BAX | 600040 | |
20q11.23 | Colon cancer, advanced, somatic | 114500 | 3 | SRC | 190090 | |
20q13.2 | {Colon cancer, susceptibility to} | 114500 | AD, SMu | 3 | AURKA | 603072 |
22q13.2 | Colorectal cancer, somatic | 114500 | 3 | EP300 | 602700 |
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
3p22.2 | Lynch syndrome 2 | 609310 | 3 | |
Mismatch repair cancer syndrome 1 | 276300 | AR | 3 | |
Muir-Torre syndrome | 158320 | AD | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
2p16.3 | {Endometrial cancer, familial} | 608089 | AD, SMu | 3 |
Lynch syndrome 5 | 614350 | AD | 3 | |
Mismatch repair cancer syndrome 3 | 619097 | AR | 3 |
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
3p22.2 | Mismatch repair cancer syndrome 1 | 276300 | AR | 3 | MLH1 | 120436 |
Location | Phenotype | Inheritance |
Phenotype mapping key |
Phenotype MIM number |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
2p21-p16.3 | Mismatch repair cancer syndrome 2 | AR | 3 | 619096 | MSH2 | 609309 |
2p16.3 | Mismatch repair cancer syndrome 3 | AR | 3 | 619097 | MSH6 | 600678 |
3p22.2 | Mismatch repair cancer syndrome 1 | AR | 3 | 276300 | MLH1 | 120436 |
7p22.1 | Mismatch repair cancer syndrome 4 | AR | 3 | 619101 | PMS2 | 600259 |
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
2p21 | Lynch syndrome 8 | 613244 | AD | 3 | EPCAM | 185535 |
Location | Phenotype | Inheritance |
Phenotype mapping key |
Phenotype MIM number |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
2p21 | Lynch syndrome 8 | AD | 3 | 613244 | EPCAM | 185535 |
2p21-p16.3 | Lynch syndrome 1 | AD | 3 | 120435 | MSH2 | 609309 |
2p16.3 | Lynch syndrome 5 | AD | 3 | 614350 | MSH6 | 600678 |
3p24.1 | Colorectal cancer, hereditary nonpolyposis, type 6 | 3 | 614331 | TGFBR2 | 190182 | |
3p22.2 | Lynch syndrome 2 | 3 | 609310 | MLH1 | 120436 | |
7p22.1 | Lynch syndrome 4 | 3 | 614337 | PMS2 | 600259 | |
14q24.3 | Colorectal cancer, hereditary nonpolyposis, type 7 | 3 | 614385 | MLH3 | 604395 |
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
2p21-p16.3 | Muir-Torre syndrome | 158320 | AD | 3 | MSH2 | 609309 |
3p22.2 | Muir-Torre syndrome | 158320 | AD | 3 | MLH1 | 120436 |
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
7p22.1 | Lynch syndrome 4 | 614337 | 3 | |
Mismatch repair cancer syndrome 4 | 619101 | AR | 3 |
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
2p21 | Diarrhea 5, with tufting enteropathy, congenital | 613217 | AR | 3 |
Lynch syndrome 8 | 613244 | AD | 3 |
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
2p21-p16.3 | Lynch syndrome 1 | 120435 | AD | 3 |
Mismatch repair cancer syndrome 2 | 619096 | AR | 3 | |
Muir-Torre syndrome | 158320 | AD | 3 |
|
|
|
|
|
|
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM